Er‐shun Liang
- Molecular Biology
- Cardiology and Cardiovascular Medicine
- Surgery
- Immunology
- Complementary and alternative medicine top 10%
- Topics
- Signaling Pathways in Disease (5 papers)Cardiovascular Function and Risk Factors (4 papers)PARP inhibition in cancer therapy (4 papers)
- Cited by
- Complementary and alternative medicineCardiology and Cardiovascular MedicineCancer Research
In The Last Decade
Er‐shun Liang
21 papers receiving 535 citations
Peers
Comparison fields: 5 of 75
- Molecular Biology 254
- Cardiology and Cardiovascular Medicine 124
- Surgery 80
- Immunology 77
- Complementary and alternative medicine 63
Countries citing papers authored by Er‐shun Liang
This map shows the geographic impact of Er‐shun Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Er‐shun Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Er‐shun Liang more than expected).
Fields of papers citing papers by Er‐shun Liang
This network shows the impact of papers produced by Er‐shun Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Er‐shun Liang. The network helps show where Er‐shun Liang may publish in the future.
Co-authorship network of co-authors of Er‐shun Liang
This figure shows the co-authorship network connecting the top 25 collaborators of Er‐shun Liang. A scholar is included among the top collaborators of Er‐shun Liang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Er‐shun Liang. Er‐shun Liang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 2 | |
| 3 | 2 | |
| 4 | 42 | |
| 5 | 5 | |
| 6 | 34 | |
| 7 | 69 | |
| 8 | 26 | |
| 9 | 14 | |
| 10 | 33 | |
| 11 | 26 | |
| 12 | 29 | |
| 13 | 38 | |
| 14 | 12 | |
| 15 | 27 | |
| 16 | 19 | |
| 17 | 29 | |
| 18 | 30 | |
| 19 | 23 | |
| 20 | 17 |
About Er‐shun Liang
Er‐shun Liang is a scholar working on Cardiology and Cardiovascular Medicine, Complementary and alternative medicine and Oncology, having authored 21 papers that have together received 540 indexed citations. Recurring topics across this work include Signaling Pathways in Disease (5 papers), Cardiovascular Function and Risk Factors (4 papers) and PARP inhibition in cancer therapy (4 papers). The work is most often cited by research in Complementary and alternative medicine (63 citations), Cardiology and Cardiovascular Medicine (124 citations) and Cancer Research (62 citations). Er‐shun Liang has collaborated with scholars based in China, Thailand and Sweden. Frequent co-authors include Yuxia Zhao, Zhanhui Du, Mingxiang Zhang, Xue Liu, Wei Gao, Qinghua Lu, Yun Zhang, Deshan Liu, Xueying Chen and Wenqian Dong. Their work appears in journals such as Biochemical and Biophysical Research Communications, Hypertension and Journal of Ethnopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.